Thai nasal-spray Covid vaccine to begin human trial in mid 2022 Thai nasal-spray Covid vaccine to begin human trial in mid 2022
SATURDAY, NOVEMBER 13, 2021
The nasal-spray Covid-19 vaccine “NASTVAC”, developed by the National Centre for Genetic Engineering and Biotechnology (Biotech), is expected to start testing on humans by April 2022, said Dr Anan Jongkaewwattana, director of the agency’s Veterinary Health Innovation and Management Research Group Unit on Friday.